✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Hanmi Pharm Co Ltd

Common Name
Hanmi Pharm
Country
South Korea
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,400
Ticker
128940
Exchange
KOREA EXCHANGE
Description
Hanmi Pharm Co., Ltd. is a prominent pharmaceutical company known for its innovative approach to drug development and manufacturing in South Korea. Its core function centers around researching and pro...

Hanmi Pharm's GHG Emissions Data Preview

In 2024, Hanmi Pharm completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Hanmi Pharm has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of Hanmi Pharm’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=128940&reporting_period=2024"

Verified Sources Behind Hanmi Pharm’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Hanmi Pharm’s data sources below and access millions more through our Disclosure Search.

a. Hanmi Pharm's ESG Report 2025
b. Hanmi Pharm's ESG Report 2024

Insights into Hanmi Pharm's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Hanmi Pharm amounted to 71,772.022 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Hanmi Pharm increased by 17.2%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Hanmi Pharm's Scope 1 Emissions Over Time

202120222023202403.5 k7 k10.5 k14 ktCO2e+9%+7%+17%
  • Total Scope 1
  • Year-over-Year Change

What are Hanmi Pharm's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Hanmi Pharm were 13,514.933 metric tons of CO₂ equivalent (tCO₂e).a

Has Hanmi Pharm reduced its Scope 1 emissions over time?

Since 2021, Hanmi Pharm's Scope 1 emissions have increased by 37.36%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), Hanmi Pharm's Scope 1 emissions increased by 17.32%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Hanmi Pharm's Scope 2 emissions?

In 2024, Hanmi Pharm reported Scope 2 greenhouse gas (GHG) emissions of 58,257.089 tCO₂e without specifying the calculation method.a

Has Hanmi Pharm reduced its Scope 2 emissions over time?

Since 2021, Hanmi Pharm's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 20.88%, reflecting a declining long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), Hanmi Pharm's Scope 2 emissions (Unspecified Calculation Method) rose by 17.17% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Hanmi Pharm use for Scope 2 reporting?

In 2024, Hanmi Pharm reported its Scope 2 emissions using an unspecified methodology.a

Hanmi Pharm's Scope 2 Emissions Over Time

2021202220232024020 k40 k60 k80 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Hanmi Pharm's Value Chain Emissions

In 2024, Hanmi Pharm reported 88,703.298 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Hanmi Pharm includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Hanmi Pharm's Scope 3 Emissions Over Time

20232024025 k50 k75 k100 ktCO2e+7%
  • Total Scope 3
  • Year-over-Year Change

What are Hanmi Pharm's Scope 3 emissions?

In 2024, Hanmi Pharm reported total Scope 3 emissions of 88,703.298 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 82.46% of these emissions originated from upstream activities such as purchased goods and capital goods, while 17.54% came from downstream activities like product use, distribution, and end-of-life treatment.a

Compared to the previous year (2023), Hanmi Pharm's Scope 3 emissions remained relatively stable, indicating that Hanmi Pharm's emissions have plateaued with no significant change in its value chain footprint.a

What categories of Scope 3 emissions does Hanmi Pharm disclose?

In 2024, Hanmi Pharm reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Hanmi Pharm's Scope 3 emissions?

In 2024, the largest contributors to Hanmi Pharm's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 49,467.161 tCO₂e (55.77%)
  • Investments (Cat. 15): 15,561.46 tCO₂e (17.54%)
  • Capital Goods (Cat. 2): 7,980.585 tCO₂e (9%)

Hanmi Pharm's Scope 3 Emissions by Categories

Investments(Cat. 15)(17.5%)Capital Goods(Cat. 2)(9.0%)Purchased Goods andServices (Cat. 1)(55.8%)

Insights into Hanmi Pharm’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Hanmi Pharm reported Scope 1 greenhouse gas (GHG) emissions of 13,514.933 tCO₂e and total revenues of USD 1,019 millions. This translates into an emissions intensity of 13.26 tCO₂e per millions USD.a

Hanmi Pharm's Scope 1 Emissions Intensity Compared to Peers

2002,00010,000100,000500,000Scope 1 Emissions (tCO2e)1002001,0005,00010,000Revenues (Millions of USD)PEJVetoquinolYear: 2024Scope 1: 7,159 tCO2eRevenue: $M 561Scope 1 Intensity: 12.76 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MMega LifesciencesYear: 2023Scope 1: 1,809 tCO2eRevenue: $M 455Scope 1 Intensity: 3.97 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MHUTCHMED (China)Year: 2024Scope 1: 3,083 tCO2eRevenue: $M 4,926Scope 1 Intensity: 0.63 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYuhanYear: 2024Scope 1: 7,059 tCO2eRevenue: $M 1,409Scope 1 Intensity: 5.01 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MEEEris LifesciencesYear: 2025Scope 1: 1,083 tCO2eRevenue: $M 337Scope 1 Intensity: 3.21 tCO2e/$MAspen Pharmacare HoldingsYear: 2025Scope 1: 32,776 tCO2eRevenue: $M 2,450Scope 1 Intensity: 13.38 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MChina Medical System HoldingsYear: 2023Scope 1: 1,628 tCO2eRevenue: $M 1,233Scope 1 Intensity: 1.32 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MHanmi PharmYear: 2024Scope 1: 13,515 tCO2eRevenue: $M 1,019Scope 1 Intensity: 13.26 tCO2e/$M

How does Hanmi Pharm's GHG emissions intensity compare to its peers?

In 2024, Hanmi Pharm reported a Scope 1 emissions intensity of 13.26 tCO₂e per millions USD. Compared to the peer group median of 19.77, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Hanmi Pharm rank on GHG emissions intensity within its industry?

In 2024, Hanmi Pharm ranked 12 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Hanmi Pharm is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Hanmi Pharm's Total Carbon Footprint

In 2024, Hanmi Pharm reported a total carbon footprint of 160,475.32 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 11.6% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Hanmi Pharm's total carbon footprint was Scope 3 emissions, accounting for 55.28% of the company's total carbon footprint, followed by Scope 2 emissions at 36.3%.a

Want Full Access to Hanmi Pharm's GHG Emissions Dataset?
Start 30-Day Free Trial